article · PubMed
Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis is characterized by neuropsychiatric symptoms, seizures, dysautonomia, and movement disorders. Initially identified as a paraneoplastic syndrome predominantly in young women with ovarian teratomas, it has become clear that not all affected individuals have tumors, and symptoms can occur across genders. With the availability of the NMDAR antibody assay, cases have also been identified in patients presenting with early psychosis, epilepsy, and classic limbic encephalitis. This emerging understanding enables earlier diagnosis, even in resource-limited settings, facilitating a multidisciplinary management approach that combines immunotherapies and tumor removal when indicated. This case highlights the importance of recognizing anti-NMDAR encephalitis in an 18-year-old female, emphasizing the need for prompt intervention to improve recovery outcomes.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.71480/nmj.v66i3.619
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.
